Author

A. Schelling

Observed names: A Schelling, A. SCHELLING, Arie Schelling

Observed institution: Sint Franciscus Gasthuis

OpenAlex ID: A5110071889

Antihypertensive Properties of the Novel Calcium Antagonist Mibefradil (Ro 40-5967)

1996 · Peter J.L.M. Bernink, Gerold Prager, et al. · Hypertension · 91

Nebivolol vs enalapril in the treatment of essential hypertension: a double-blind randomised trial

1997 · L Van Nueten, A Schelling, et al. · Journal of Human Hypertension · 48

A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles

1997 · RJ Viskoper, PJLM Bernink, et al. · Journal of Human Hypertension · 25

Cardiovascular effects of sulmazol administered intravenously to patients with severe heart failure

1984 · F. HAGEMEIJER, A. SEGERS, et al. · European Heart Journal · 13

Adaptive changes in the acute haemodynamic effects of cilazapril during chronic treatment

1996 · J. Larsen, R. Sykulski, et al. · European Journal of Clinical Pharmacology · 9

Combination of Calcium Channel Blockers and Beta Blockers for Patients with Exercise-Induced Angina Pectoris: A Double-Blind Parallel-Group Comparison of Different Classes of Calcium Channel Blockers

1999 · J.A.F.M. van der Vring, M.C.G. Daniëls, et al. · Angiology · 5

Hemodynamic effects of the new inotropic agent sulmazol (AR-L115 BS) administered intravenously to patients with severe heart failure.

1983 · F Hagemeijer, R van Mechelen, et al. · PubMed · 2

Effets hémodynamiques d'une perfusion intraveineuse d'amrinone à doses croissantes chez douze patients en décompensation cardiaque sévère

1987 · F. Hagemeijer, C. t'Hart, et al. · La Revue de Médecine Interne

Works count: 8

Citation count: 193

H-index: 5

I10-index: 4